Inscrivez-vous pour créer des alertes relatives aux instruments,
aux événements économiques et au contenu publié par vos auteurs préférés
Inscription gratuite Vous avez déjà un compte ? Connexion
323,240
+2,780
+0,87%
Cotations
Tous types d’instruments
- Tous types d’instruments
- Indices
- Actions
- ETF
- Fonds
- Mat. prem.
- Devises
- Crypto
- Oblig.
- Certificats
Merci d'essayer une autre recherche
🚨 Marchés volatils ? Trouvez des perles cachées pour une performance explosive
Trouver des actions maintenant
Axa World Funds - Longevity Economy F Capitalisation Usd (0P00007Y4O)
Ajouter au/Supprimer du portefeuille
Ajout au Portefeuille
Type:
Fonds
Marché:
Luxembourg
Emetteur:
AXA Funds Management S.A.
ISIN:
LU0266013803
Catégorie d'actif:
Action
AXA World Funds - Framlington Health F Capitalisat
323,240
+2,780
+0,87%
Vue d'ensemble 0P00007Y4O
Sur cette page vous trouverez un profil détaillé de Axa World Funds - Longevity Economy F Capitalisation Usd. Vous y trouverez notamment des informations sur la gestion, le total des actifs, la stratégie d'investissement et les coordonnées de 0P00007Y4O entre autres informations.
Stratégie d’investissement
AXA WF Framlington Health s'adresse aux investisseurs qui ont pour objectif de valorer leur capital en se positionnant sur des actions issues de sociétés du secteur médical et des services et produits médicaux à l'échelle mondiale. Les investissements sont réalisés dans le secteur pharmaceutique, les compagnies biotechnologiques, les instruments médicaux et manufacturiers, les distributeurs de produits médicaux et autres compagnies de services médicaux. Le processus d'investissement se base sur une approche GARP utilisant une approche bottom-up dans la sélection des titres.
Contact
Adresse
Paseo de la Castellana 93, 6a planta
Madrid,none 28046
Spain
Madrid,none 28046
Spain
Téléphone
+34 91 406 72 18
Fax
+34 91 406 72 01
Web
www.axa-im.es
Principaux dirigeants
| Nom | Titre | Depuis | Jusqu’à |
|---|---|---|---|
| Gregg Bridger | - | 2023 | Maintenant |
| Biographie | Gregg Bridger is a fund manager in the global equities team. Prior to joining FOUR, he was employed as a Product Specialist in the Fundamental equities team at Goldman Sachs Asset Management. Previously, Gregg was an assistant portfolio manager in the emerging markets equity team at Credit Suisse. Gregg holds a BA (Hons) in Economics from the University of Leicester and is a CFA Charterholder. | ||
| Stephen Kelly | Portfolio Manager | 2023 | Maintenant |
| Biographie | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Stephen Kelly | Portfolio Manager | 2021 | 2023 |
| Biographie | Stephen graduated from the University of Exeter in 1990 with an honours degree in Economics. He joined Olliff & Partners as a trainee in the equity research department where he covered the UK paper and packaging sector. In February 1992 he joined the US Desk at Capel Cure Myers as an assistant Fund Manager and in December 1995 was promoted to Fund Manager.Stephen joined Framlington in 1997 as a Fund Manager on the US Desk responsible for the US and technology. | ||
| Peter Hughes | Portfolio Manager | 2021 | 2023 |
| Biographie | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Linden Thomson | - | 2015 | 2021 |
| Dani Saurymper | - | 2015 | 2021 |
| Biographie | Dani Saurymper joined AXA IM in April 2015 as Fund Manager for the AXA Framlington Health Fund. He joined from Barclays Capital where he was a senior equity research analyst covering European healthcare. | ||
| Peter Hughes | Portfolio Manager | 2007 | 2021 |
| Biographie | Peter joined Redwheel in July 2023 as a Partner and Portfolio Manager. He will manage the Redwheel Life Changing Treatments strategy. His ambition for the role is to focus on improving patients’ lives, regardless of where they live by investing in companies facilitating improved health care outcomes while providing long-term capital appreciation for investors. Before Redwheel, Peter was Portfolio Manager of the AXA World Funds Longevity Economy fund and AXA Framlington Health fund, specialising in healthcare. Before this, he held appointments at Architas, in roles covering investment research and relationship management. Peter holds a PhD in biochemistry from University College London. He has a master's degree in chemistry from the University of Surrey and is a CFA Charterholder. He is also an ambassador for the Royal Marsden Cancer Charity. Peter was named as a 2021 Rising Star of Asset Management by Financial News. | ||
| Gemma Game | - | 2009 | 2015 |
| Deane Donnigan | clinical Specialist | 2007 | 2008 |
| Biographie | Deane joined Polar Capital in June 2013 as a senior analyst for the Healthcare team and has over 34 years’ industry experience, including over 15 years within healthcare asset management. She trained as a clinical pharmacist, graduating with a post baccalaureate Doctor of Pharmacy from the University of Georgia. Deane began her career at the Medical College of Georgia, before becoming a clinical specialist in Drug Information and Adult Internal Medicine with Emory University Hospital in Atlanta, Georgia. After several years, she moved to the UK to join Framlington (now AXA Framlington) applying her extensive pharmaceutical expertise working as an analyst for the healthcare unit trust, led by Anthony Milford. She went on to become lead portfolio manager of the Framlington Healthcare and Framlington Biotechnology funds. Deane is both a US and UK citizen. | ||
Exprimez-vous à propos de Axa World Funds - Longevity Economy F Capitalisation Usd
Êtes-vous sûr de vouloir supprimer ce graphique ?
Supprimer Annuler
Remplacer le graphique actuel par un nouveau graphique?
Remplacer Annuler
Charte de discussion
Ajouter un graphique au commentaire
Confirmer le blocage
Voulez-vous vraiment bloquer %USER_NAME% ?
Si vous continuez, vous et %USER_NAME% ne verrez plus vos publications Investing.com mutuelles.
%USER_NAME% a bien été ajouté à votre Liste d’utilisateurs bloqués
Vous venez de débloquer cette personne et devrez attendre 48 heures avant de la bloquer de nouveau.
Signaler ce commentaire comme inapproprié
Je souhaite signaler ce commentaire comme:
Commentaire signalé
Merci
Le commentaire signalé sera révisé par nos modérateurs